Clinical Variants of Pityriasis Rosea

Overview

Journal World J Clin Cases

Publisher Baishideng Publishing Group

Specialty General Medicine

Date 2017 Jul 8

PMID 28685133

Citations 13

Authors

Francisco Urbina

Anupam Das

Emilio Sudy

Affiliations

Soon will be listed here.

Abstract

Pityriasis rosea (PR) is a common erythemato-squamous dermatosis which almost always, is easily diagnosed. Mostly the disease presents in its classical form. However, clinical dermatology is all about variations and PR is not an exception. Variants of the disease in some cases may be troublesome to diagnose and confuse clinicians. Prompt diagnosis and treatment of the condition becomes necessary to avoid unnecessary investigations. We hereby review and illustrate atypical presentations of the disease, including diverse forms of location and morphology of the lesions, the course of the eruption, and its differential diagnoses.

Citing Articles

Herald Patch as the Only Evidence of Pityriasis Rosea: Clinical, Laboratory and Pathogenetic Features.

Drago F, Herzum A, Varesano S, Serviddio G, Broccolo F, Ciccarese G Viruses. 2025; 17(1).

PMID: 39861908 PMC: 11768941. DOI: 10.3390/v17010119.

Beyond the Herald Patch: Exploring the Complex Landscape of Pityriasis Rosea.

Mashoudy K, Kim S, Farhadi L, Elman S Am J Clin Dermatol. 2025; 26(2):237-250.

PMID: 39798062 PMC: 11850427. DOI: 10.1007/s40257-024-00915-7.

Challenges in designing studies assessing birth complications and spontaneous abortion in pregnant patients with pityriasis rosea.

Ong M, Lipner S J Am Acad Dermatol. 2024; 91(5):e125-e126.

PMID: 39047978 PMC: 11674296. DOI: 10.1016/j.jaad.2024.05.102.

A Cross-Sectional Study of Epidemiological and Clinical Aspects of Pityriasis Rosea along with Dermoscopic Analysis and Histopathology Correlation.

Shende A, Chikhalkar S Indian J Dermatol. 2024; 69(2):145-151.

PMID: 38841213 PMC: 11149824. DOI: 10.4103/ijd.ijd_1071_23.

Pityriasis following COVID-19 vaccinations: a systematic review.

Duzett L, Mercado G, Tasouli-Drakou V, Kane A, Tam A Dermatol Reports. 2024; 16(1):9742.

PMID: 38623364 PMC: 11017724. DOI: 10.4081/dr.2023.9742.

References

Chuang T, Ilstrup D, PERRY H, Kurland L . Pityriasis rosea in Rochester, Minnesota, 1969 to 1978. J Am Acad Dermatol. 1982; 7(1):80-9. DOI: 10.1016/s0190-9622(82)80013-3. View

Drago F, Ciccarese G, Broccolo F, Cozzani E, Parodi A . Pityriasis Rosea in Children: Clinical Features and Laboratory Investigations. Dermatology. 2015; 231(1):9-14. DOI: 10.1159/000381285. View

Papakostas D, Stavropoulos P, Papafragkaki D, Grigoraki E, Avgerinou G, Antoniou C . An atypical case of pityriasis rosea gigantea after influenza vaccination. Case Rep Dermatol. 2014; 6(1):119-23. PMC: 4025149. DOI: 10.1159/000362640. View

Singh S, Singh S, Pandey S . Recurrent pityriasis rosea. Indian J Dermatol Venereol Leprol. 2010; 64(5):237. View

Griffiths A . Vesicular pityriasis rosea. Arch Dermatol. 1977; 113(12):1733-4. View

Olumide Y . Pityriasis rosea in Lagos. Int J Dermatol. 1987; 26(4):234-6. DOI: 10.1111/j.1365-4362.1987.tb00907.x. View

Zawar V, Kumar R . Multiple recurrences of pityriasis rosea of Vidal: a novel presentation. Clin Exp Dermatol. 2009; 34(5):e114-6. DOI: 10.1111/j.1365-2230.2008.03167.x. View

Buckley C . Pityriasis rosea-like eruption in a patient receiving omeprazole. Br J Dermatol. 1996; 135(4):660-1. DOI: 10.1111/j.1365-2133.1996.tb03863.x. View

Zawar V, Chuh A . Follicular pityriasis rosea. A case report and a new classification of clinical variants of the disease. J Dermatol Case Rep. 2012; 6(2):36-9. PMC: 3399673. DOI: 10.3315/jdcr.2012.1095. View

10.

Mahajan K, Relhan V, Relhan A, Garg V . Pityriasis Rosea: An Update on Etiopathogenesis and Management of Difficult Aspects. Indian J Dermatol. 2016; 61(4):375-84. PMC: 4966395. DOI: 10.4103/0019-5154.185699. View

11.

Bedane C, Lavignac C, Bernard P, Bonnetblanc J . [Cutaneous reactions to gold salts]. Ann Dermatol Venereol. 1994; 121(11):793-7. View

12.

Bonnetblanc J . [Cutaneous reactions to gold salts]. Presse Med. 1996; 25(32):1555-8. View

13.

Garcia R . Letter: Vesicular pityriasis rosea. Arch Dermatol. 1976; 112(3):410. View

14.

Rassai S, Feily A, Sina N, Abtahian S . Low dose of acyclovir may be an effective treatment against pityriasis rosea: a random investigator-blind clinical trial on 64 patients. J Eur Acad Dermatol Venereol. 2010; 25(1):24-6. DOI: 10.1111/j.1468-3083.2010.03676.x. View

15.

Friedman S . Pityriasis rosea with erythema multiforme-like lesions. J Am Acad Dermatol. 1987; 17(1):135-6. DOI: 10.1016/s0190-9622(87)80542-x. View

16.

Eslick G . Atypical pityriasis rosea or psoriasis guttata? Early examination is the key to a correct diagnosis. Int J Dermatol. 2002; 41(11):788-91. DOI: 10.1046/j.1365-4362.2002.01627.x. View

17.

Chuh A, Zawar V, Sciallis G, Kempf W . A position statement on the management of patients with pityriasis rosea. J Eur Acad Dermatol Venereol. 2016; 30(10):1670-1681. DOI: 10.1111/jdv.13826. View

18.

Das A, Sarkar T, Chandra S, Ghosh A, Gharami R . A case series of erythema multiforme-like pityriasis rosea. Indian Dermatol Online J. 2016; 7(3):212-5. PMC: 4886603. DOI: 10.4103/2229-5178.182374. View

19.

HELFMAN R, Brickman M, Fahey J . Isotretinoin dermatitis simulating acute pityriasis rosea. Cutis. 1984; 33(3):297-300. View

20.

Broccolo F, Drago F, Careddu A, Foglieni C, Turbino L, Cocuzza C . Additional evidence that pityriasis rosea is associated with reactivation of human herpesvirus-6 and -7. J Invest Dermatol. 2005; 124(6):1234-40. DOI: 10.1111/j.0022-202X.2005.23719.x. View